Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating ...
Craig-Hallum analyst William Bonello maintained a Buy rating on Guardant Health (GH – Research Report) today. The company’s shares closed ...
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it ...
5d
FOX 4 Dallas-Fort Worth on MSNNew blood test helps Texas doctors detect colon cancer in patients earlierDoctors in Dallas and other parts of Texas are beginning to use a new blood test that can detect colon cancer earlier. The ...
6d
Axios Austin on MSNAustin gets access to new blood tests for colorectal cancerAustin patients are among the first in the country to have access to a new blood test capable of screening for colorectal ...
Of the 30 companies included, 19 companies saw their stock price increase, eight firms saw their share price decrease, and three companies remained essentially flat.
Some of the best health care stocks for February 2025, based on 30-day returns, include Akero Therapeutics Inc., Guardant Health Inc., and Inari Medical Inc. The best-performing health care stocks in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results